跳至主要内容
临床试验/NCT05628285
NCT05628285已完成不适用

Evaluation of a Sound Processor for a Transcutaneous System

Oticon Medical1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2022年11月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
11
试验地点
1
主要终点
To Assess the Improvement of Hearing With the Sentio1 (PTA4)

研究概览

简要总结

A single center study evaluating the performance of an externally worn sound processor for a transcutaneous bone anchored hearing system using audiological outcomes measures such as aided thresholds and self-evaluation questionnaires.

详细描述

Bone conduction hearing systems use the body's natural ability to transfer sound through bone conduction. The sound processor picks up sound and converts it into vibrations that are transferred through the skull bone to the inner ear (cochlea). Thus, for patients with conductive or mixed hearing losses, patients with lasting hearing loss following a middle ear disease or malformations (such as microtia), the vibrations are bypassing the conductive problem in the ear canal or middle ear. Bone conduction devices currently on the market are divided into three types; transcutaneous direct drive, percutaneous (skin penetrating) direct drive and transcutaneous skin drive bone conduction devices. This evaluation focus on a sound processor used for a transcutaneous system.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Signed Informed Consent Form
  • •Adult subjects (18 years or older)
  • •Subjects implanted with an I1 implant
  • •Fluent in Swedish

排除标准

  • •Subjects who do not have the ability or are un-willing to follow investigational procedures/requirements, e.g., to complete questionnaires, according to investigator's discretion.
  • •Subject deemed unsuitable for any medical or other reason as judged by PI or medical responsible.

研究组 & 干预措施

Sentio 1 sound processor

Experimental

The sound processor picks up the sound and transfer it to the implant that convert the sound to vibrations that are transmitted to the inner ear.

干预措施: Sentio 1 (Device)

结局指标

主要结局

To Assess the Improvement of Hearing With the Sentio1 (PTA4)

时间窗: 1 month

Functional gain with Sentio 1, i.e., the difference in dB between unaided and aided sound field thresholds, calculated on average for frequencies 500, 1000, 2000 and 4000 Hz (PTA4). In detail, for each patient, sound field thresholds are measured at the frequencies 500, 1000, 2000 and 4000 Hz for which a mean value is calculated and denoted as PTA4. The primary outcome measure is functional gain which is the difference in PTA4 measured unaided (without sound processor) versus aided condition (with sound processor).

次要结局

  • Subjective Evaluation of Sound Processor Performance.(1 month)
  • Subjective Sound Processor Preference(1 month)
  • Assess Safety With the Sentio 1 Sound Processor(12 months)
  • To Assess the Improvement of Hearing With the Sentio1(1 month)
  • To Assess the Difference Between BC In-situ Thresholds Measured With Sentio 1 and Conventional Unmasked BC Audiometry.(1 month)
  • To Assess the Degree to Which Sentio 1 Compensates for the BC Hearing Loss(1 month)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验